Fraction dose escalation
Showing 1 - 25 of >10,000
Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Split-course hypo-CCRT, Induction chemo-immunotherapy, Concurrent chemo)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Split-course hypo-CCRT
- +2 more
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Aug 26, 2023
Breast Cancer Trial in Dallas (Radiomics on MRI)
Recruiting
- Breast Cancer
- Radiomics on MRI
-
Dallas, TexasUniversity of Texas Southwestern Medical Center - Dallas
Nov 28, 2022
Palliative Radiotherapy Trial in Saint Leonards (dose escalation)
Recruiting
- Palliative Radiotherapy
- dose escalation
-
Saint Leonards, New South Wales, AustraliaRoyal North Shore Hospital
Oct 25, 2022
Brain Metastases Trial in Birmingham (Dose Escalated Five Fraction Stereotactic Radiosurgery)
Recruiting
- Brain Metastases
- Dose Escalated Five Fraction Stereotactic Radiosurgery
-
Birmingham, AlabamaHazelrig-Salter Radiation Oncology Center
Mar 25, 2022
Lung Cancer Trial in Indianapolis (Stereotactic Ablative Body Radiation (SABR))
Terminated
- Lung Cancer
- Stereotactic Ablative Body Radiation (SABR)
-
Indianapolis, Indiana
- +2 more
Jul 22, 2022
Heart Failure With Preserved Ejection Fraction Trial (HU6, Placebo)
Recruiting
- Heart Failure With Preserved Ejection Fraction
- HU6
- Placebo
-
Hialeah, Florida
- +3 more
Dec 19, 2022
Metastatic Spine Lesions Trial in New York (single-fraction radiation, MRI and/or CT)
Active, not recruiting
- Metastatic Spine Lesions
- single-fraction radiation
- MRI and/or CT
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 29, 2021
Ventricular Tachycardia, Arrhythmia, Arrhythmic Storm Trial in Montreal (stereotactic body radiotherapy, 20 Gy in 1 fraction)
Enrolling by invitation
- Ventricular Tachycardia
- +3 more
- stereotactic body radiotherapy, 20 Gy in 1 fraction
-
Montreal, Quebec, CanadaCedars Cancer Center, McGill University Health Centre
Jun 1, 2022
Locally Advanced Lung Carcinoma Trial in Guangzhou (Concurrent chemo and single radiation dose climbing)
Recruiting
- Locally Advanced Lung Carcinoma
- Concurrent chemotherapy and single radiation dose climbing
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Jul 11, 2021
Thoracoabdominal Wall Pain, Secondary to Parietal Pleura or Parietal Peritoneum Disease Trial in United States (Single-fraction
Recruiting
- Thoracoabdominal Wall Pain
- Secondary to Parietal Pleura or Parietal Peritoneum Disease
- Single-fraction stereotactic radiosurgery (SRS)
-
Basking Ridge, New Jersey
- +6 more
Aug 2, 2023
Breast Cancer Trial in United States (GammaPod Radiation)
Recruiting
- Breast Cancer
- GammaPod Radiation
-
Baltimore, Maryland
- +3 more
Nov 8, 2021
Non-hodgkin Lymphoma, Hodgkin Lymphoma, Lymphoma Trial in Chicago (Radiation - Dose Level 0, Radiation - Dose Level 1, Radiation
Recruiting
- Non-hodgkin Lymphoma
- +2 more
- Radiation - Dose Level 0
- +4 more
-
Chicago, IllinoisUniversity of Chicago
Dec 3, 2021
Head and Neck Squamous Cell Carcinoma Trial in Delhi (DE-HyART, Standard Arm, Cisplatin injection)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- DE-HyART
- +3 more
-
Delhi, IndiaRajiv Gandhi Cancer Institute and Research Centre
Oct 20, 2023
Glioblastoma Trial (Dose escalation of radiation dose beyond the therapeutic standard)
Not yet recruiting
- Glioblastoma
- Dose escalation of radiation dose beyond the therapeutic standard
- (no location specified)
May 13, 2023
Heart Failure With Preserved Ejection Fraction Trial in United States (JK07, Matching Placebo)
Recruiting
- Heart Failure With Preserved Ejection Fraction
- JK07
- Matching Placebo
-
Stanford, California
- +6 more
Jan 30, 2023
Heart Failure With Reduced Ejection Fraction Trial (AC01)
Not yet recruiting
- Heart Failure With Reduced Ejection Fraction
- (no location specified)
Jan 31, 2023
Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- HP518 - Dose Escalation
- HP518 -Dose Expansion
- (no location specified)
Dec 1, 2023
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)
Not yet recruiting
- Triple Negative Breast Cancer
- +13 more
- (no location specified)
Aug 29, 2023
Localized Prostate Carcinoma Trial in Milan (prostate SBRT)
Not yet recruiting
- Localized Prostate Carcinoma
- prostate SBRT
-
Milan, MI, ItalySan Raffaele Scientific Institute
Jun 29, 2023
Non-Alcoholic Fatty Liver Disease, Steatosis of Liver Trial in Ramat Gan (Ultra Low Dose CT, Fat quantification MRI)
Enrolling by invitation
- Non-Alcoholic Fatty Liver Disease
- Steatosis of Liver
- Ultra Low Dose CT
- Fat quantification MRI
-
Ramat Gan, IsraelProf. Noam Tau
Jan 29, 2023
Colorectal Cancer, Esophagus Cancer, Appendix Cancer Trial (FOX dose-escalation algorithm)
Not yet recruiting
- Colorectal Cancer
- +4 more
- FOX dose-escalation algorithm
- (no location specified)
Mar 24, 2023
Breast Cancer Trial (Standard of care administration of Endocrine therapy, Dose-frequency escalation administration of Endocrine
Not yet recruiting
- Breast Cancer
- Standard of care administration of Endocrine therapy
- Dose-frequency escalation administration of Endocrine therapy
- (no location specified)
Feb 22, 2023
Prostate Adenocarcinoma, Localized Prostate Carcinoma Trial in San Francisco (High Dose Rate Monotherapy)
Not yet recruiting
- Prostate Adenocarcinoma
- Localized Prostate Carcinoma
- High Dose Rate Monotherapy
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 27, 2022
Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)
Active, not recruiting
- Astrocytoma, Grade IV
- +3 more
- Radiation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023